Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

This study is based on an evaluation of a safer supply program (SSP) in a medium-sized urban centre with a large catchment area that includes rural and Indigenous communities.

Original research | 2024
About PWUD, Barriers and enablers, Equity, Indigenous, Safer supply, Small/medium cities

We aimed to determine the extent to which uptake and discontinuation of an initial attempt at a prescribed safer supply (PSS) program were influenced through networks of prescribers.

Original research | 2024
About prescribers, Hesitancy of prescribers , Evidence base, Outcomes, Policy/Regulatory, Safer supply, Transitions in care/treatment, Workplace
Original research | 2024
Policy/Regulatory, Safer supply

The aim of this submission is to clarify the research and statistics behind injection-related infections among individuals on safer opioid supply (SOS)--daily dispensed immediate-release hydromorph

Letter | 2024
About PWUD, Advocacy, Evidence base, Hospitals, Injecting drugs, Opioids, Safer supply
Essay | 2024
About PWUD, Barriers and enablers, Diversion, Evidence base, Hesitancy of prescribers , Legal system/law enforcement, Overdose, Policy/Regulatory, Safer supply, Stigma, Youth

We examined the number and characteristics of high-volume buprenorphine prescribers and the nature of their buprenorphine prescribing from 2009 to 2018.

Original research | 2024
About prescribers, Substitution/OAT

Canadian Opioid Agonist Therapy (OAT) guidelines outline take-home dose (THD) criteria, yet, OAT prescribers use their clinical judgement to decide whether an individual is ‘clinically stable’ to r

Lit review | 2024
About PWUD, Barriers and enablers, Carries/take-home doses, Equity, Hesitancy of prescribers , Stigma, Substitution/OAT, Transitions in care/treatment, Treatment/recovery
Article | 2024
Harm reduction, Illegal drugs, Mortality, Overdose, Safer supply, SCS/OPS
Essay | 2024
Advocacy, Crime, Decriminalization/legalization, Equity, Harm reduction, Illegal drugs, Indigenous, Legal system/law enforcement, Peer/PWLLE program involvement, Stigma
Guidelines | 2021
About prescribers, Alcohol, Benzodiazepines, Cannabis, Chronic pain, Clinical guidance, Harm reduction, Mental health, Opioids, Substitution/OAT, Transitions in care/treatment, Withdrawal

To identify individual and initial prescription-related factors associated with an increased risk for opioid-related misuse, poisoning and dependence (MPD) in patients with non-cancer pain.

Original research | 2024
Chronic pain, Mortality, Opioids, Outcomes, Overdose, Sex/Gender , Transitions in care/treatment

We compared prescription opioid pain medication dispensing for patients with schizophrenia (SZ) or bipolar disorder (BD) versus controls over 5 years, to assess opioid dispensing trends and comorbi

Original research | 2024
Chronic pain, Mental health, Opioids, Social benefits

Did trends in postrelease treatment and outcomes for opioid use disorder change after Massachusetts prison system implemented buprenorphine treatment during incarceration?

Original research | 2024
Harm reduction, Legal system/law enforcement, Mortality, Outcomes, Overdose, Sex/Gender , Substitution/OAT, Transitions in care/treatment

To develop an individual-level prediction tool for risk of return to use in opioid use disorder.

Original research | 2023
Illegal drugs, Outcomes, Opioids, Substitution/OAT, Stimulants, Return to use, Treatment/recovery

To evaluate the impact of the tightened Pharmaceutical Benefits Scheme (PBS) prescribing rules for immediate release (IR) and controlled release (CR) opioid medicines (1 June 2020), which also elim

Original research | 2024
Barriers and enablers, Opioids, Policy/Regulatory, Social benefits

This personal view paper summarises substantial gaps in our understanding of opioid withdrawal that are likely to continue to limit major advancements in its treatment. 

Perspective | 2024
Illegal drugs, Opioids, Stimulants, Substitution/OAT, Withdrawal

To examine the relationship between the total number of months with an active buprenorphine prescription (retention) and the odds of an adverse outcome within the 12 months following an index non-f

Original research | 2024
Hospitals, Outcomes, Overdose, Substitution/OAT, Withdrawal, Treatment/recovery

The current study uses narrative analysis and framing theory to explore the series "Dopesick" (2021), discussing its portrayal of the people and themes involved in the USA opioid crisis.

Original research | 2024
Chronic pain, Opioids, Overdose, Stigma

This study explores perceptions and experiences of overdose among people who smoke drugs.

Original research | 2024
About PWUD, Illegal drugs, Overdose

Affiner votre recherche

Mots clés
Format
Région